Skip to content

Comparison of the efficacy of platelet rich plasma injection which extracted by two methods and placebo on pain, range of motion and function of patients with osteoarthritis of the knee

A Comparative Study of the Efficacy of single and double Centrifuged platelet rich plasma and placebo (normal saline injection) on Pain, ROM and Physical Function of Patients with Knee Osteoarthritis: A Double Blinded Controlled Randomized Trial with a Three-Month Follow –up

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140907019073N5
Enrollment
45
Registered
2021-07-10
Start date
2021-07-23
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group 1: The Group which treated by injection of platelet-rich plasma extracted single centrifuged. Preparation of PRP solution and injection will be done in the sports me

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with grade 2 or 3 primary osteoarthritis of the knee as determined by the Kellgren and Lawrence criteria. (Associated with knee pain, morning stiffness less than 30 minutes, crepitus on movement and radiological signs of osteoarthritis include joint space loss, subchondral bone sclerosis and the formation of osteophytes in knee) Patients aged 50-75 years. Patients who have persistent knee pain for at least six months and with an intensity of at least 4 according to the VAS scale in activities such as going up and down stairs, sitting for long periods and squatting. Patients who are able to walk independently for at least 30 meters. Patients with a body mass index equal to or less than 35. The patient has full consent to participate in the study. The patient has a balanced mental state.

Exclusion criteria

Exclusion criteria: The patient has a history of intra-articular injection in the knee during the last six months. The patient has neuromuscular diseases. The patient has a history of acute traumatic injury to other ligaments and structures of the knee joint with the approval of a specialist. The patient has a history of surgery or previous injury in the knee and other lower limb joints over the last year. The patient has bone implants. The patient has a new fracture in the lower extremities during the last year. The patient has malignant tumors. The patient has participated in exercise therapy and physiotherapy programs during the last three months.

Design outcomes

Primary

MeasureTime frame
Knee function with WOMAC(Western Ontario and McMaster Universities Osteoarthritis Index) scale. Timepoint: Before the intervention and one month and three months after the intervention. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index questionnaire.;Feeling knee pain by Visual Analogue Scale (VAS). Timepoint: Before the intervention and one month and three months after the intervention. Method of measurement: Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
Knee range of motion. Timepoint: Before the intervention, one month and three months after the intervention. Method of measurement: Goniometry.;Timed Up & Go test: The ability of a person to get up from a chair over a distance of 3 meters and return to the chair. Timepoint: Before the intervention, one month and three months after the intervention. Method of measurement: Stopwatch (seconds).;Six Minute Walk test: The person's ability to walk for 6 minutes. Timepoint: Before the intervention, one month and three months after the intervention. Method of measurement: Distance measurement (meter).;Stair climbing test: The ability of a person to climb stairs to reach the stage of pain or fatigue. Timepoint: Before the intervention, one month and three months after the intervention. Method of measurement: The number of steps taken.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Mazaherinezhad

Iran University of Medical Sciences

mazaherinezhad.a@iums.ac.ir+98 21 6435 2446

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026